Algernon Announces Enrollment of 100 Patients in 2b/3 Human Study for Treatment of COVID-19 Algernon is pleased to announce that it has now enrolled 100 patients, which is two thirds of it enrollment target...
Revive Therapeutics Announces Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19 The Company has selected and finalized with five clinical sites in Florida, Texas and California for enrollment of patients in the Phase 3..
Monterey Minerals Sells its Southern Pilbara Tenements and Options its Northern Pilbara Tenements Monterey Minerals Inc. is pleased announced that it has signed a purchase and sale agreement to sell four of its southern tenements...
